Cargando…
NCL Inhibition Exerts Antineoplastic Effects against Prostate Cancer Cells by Modulating Oncogenic MicroRNAs
Prostate cancer (PCa) is the most frequently diagnosed cancer in men and second most common cause of cancer-related deaths in the United States. Androgen deprivation therapy (ADT) is only temporarily effective for advanced-stage PCa, as the disease inevitably progresses to castration-resistant prost...
Autores principales: | Sheetz, Tyler, Mills, Joseph, Tessari, Anna, Pawlikowski, Megan, Braddom, Ashley E., Posid, Tasha, Zynger, Debra L., James, Cindy, Embrione, Valerio, Parbhoo, Kareesma, Foray, Claudia, Coppola, Vincenzo, Croce, Carlo M., Palmieri, Dario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408652/ https://www.ncbi.nlm.nih.gov/pubmed/32664322 http://dx.doi.org/10.3390/cancers12071861 |
Ejemplares similares
-
A novel fully human anti-NCL immunoRNase for triple-negative breast cancer therapy
por: D'Avino, Chiara, et al.
Publicado: (2016) -
Ran Binding Protein 9 (RanBP9) is a novel mediator of cellular DNA damage response in lung cancer cells
por: Palmieri, Dario, et al.
Publicado: (2016) -
Photoelectron Photoion Coincidence Spectroscopy of NCl(3) and NCl(2)
por: Gerlach, Marius, et al.
Publicado: (2021) -
In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation
por: Pichiorri, Flavia, et al.
Publicado: (2013) -
Genetic ablation of interacting with Spt6 (Iws1) causes early embryonic lethality
por: Orlacchio, Arturo, et al.
Publicado: (2018)